Results 21 to 30 of about 240,962 (71)

Advances in modified gallium lanthanum sulphide (Ga:La:S) glass for optical fibre devices

, 2001
The advantages of gallium lanthanum sulphide (GLS) based glass over other competing glasses for active and infrared applications are evident through its low-phonon energy, high rare-earth solubility, high transition temperature and non-toxicity.
Harwood, D.W.J., Fu, A., Petrovich, M., Arshad K. Mairaj, A. Fu, L.N. Ng, N. G. Broderick, Mairaj, A., Daniel W. Hewak, Petrovich, Marco N., Monro, T.M., Harwood, D., Hewak, D., Mairaj, Arshad K., Tanya M. Monro, D. W. J. Harwood, West, Y., Monro, T., Broderick, N., Yvonne D. West, Marco N. Petrovich, Broderick, N.G., Ng, L., West, Yvonne D., Ng, L.N.   +24 more
core   +1 more source

The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients

, 2012
Takashi Shigematsu, Yuri Nakashima, Masaki Ohya, Koichi Tatsuta, Daisuke Koreeda, Wataru Yoshimoto, Shintaro Yamanaka, Toshifumi Sakaguchi, Yoshiyuki Hanba, Toru Mima, Shigeo NegiDivision of Nephrology, Department of Internal Medicine, Wakayama Medical ...
Shigematsu T, Yoshimoto W, Koreeda D, Sakaguchi T, Nakashima Y, Negi S, Yamanaka S, Mima T, Tatsuta K, Ohya M, Hanba Y   +10 more
core  

The effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease

, 2003
: Lanthanum carbonate (Fosrenol(TM), Shire Pharmaceuticals) is a novel treatment for hyperphosphataemia. In this open-label study, we compared the effects of lanthanum carbonate and calcium carbonate on bone in dialysis patients.
de Broe, M.E.
core   +1 more source

Lanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease Stage 5 receiving hemodialysis.

, 2009
AIMS: The efficacy and tolerability of the phosphate binder, lanthanum carbonate, have been evaluated in long-term comparative studies and subsequent open-label extensions.
J,, Barnett, M E, Lanthanum Carbonate Study Group, Hutchison, A J, Krause, R, Kopyt, Nelson, DO, FASN, FACP, Siami, G A   +6 more
core  

Preparation, physical-chemical characterisation and cytocompatibility of calcium carbonate cements [PDF]

, 2006
The feasibility of calcium carbonate cements involving the recrystallisation of metastable calcium carbonate varieties has been demonstrated. Calcium carbonate cement compositions presented in this paper can be prepared straightforwardly by simply mixing
Bareille, Reine, Combes, Christèle, Miao, Baoji, Rey, Christian   +3 more
core   +1 more source

Effects of lanthanum carbonate versus calcium carbonate on vascular stiffness and bone mineral metabolism in hemodialysis patients with type 2 diabetes mellitus: a randomized controlled trial

, 2015
Kentaro Wada,1 Yuko Wada,2 Haruhito Adam Uchida,3 Shuichi Tsuruoka4 1Division of Nephrology and Dialysis, Department of Internal Medicine, Nippon Kokan Fukuyama Hospital, Hiroshima, 2Department of Internal Medicine, Central Hospital, Hiroshima ...
Uchida HA, Tsuruoka S, Wada K, Wada Y
core  

Long-Term Efficacy and Tolerability of Lanthanum Carbonate: Results from a 3-Year Study [PDF]

, 2013
Background: Control of serum phosphate over the long term is essential in patients with end-stage renal disease. Six-month and 2-year extensions to a 6-month study evaluated the long-term safety, tolerability and effi cacy of the new phosphate binder ...
Jamar, Rene, Vanwalleghem, Johan, Schmieder, Roland E., Vosskühler, Andre, Asmus, Gernot, Maes, Bart, Hutchison, Alastair J., Mohamed, Elfatih, Backs, Wolfgang   +8 more
core   +1 more source

Efficacy, Tolerability, and Safety of Lanthanum Carbonate in Hyperphosphatemia: A 6-Month, Randomized, Comparative Trial versus Calcium Carbonate [PDF]

, 2013
Background/Aims: Hyperphosphatemia is an important clinical consequence of renal failure, and its multiple adverse systemic effects are associated with signifi cantly increased risks of morbidity and mortality in dialysis patients.
Jamar, Rene, Vanwalleghem, Johan, Schmieder, Roland E., Vosskühler, Andre, Asmus, Gernot, Maes, Bart, Hutchison, Alastair J., Mohamed, Elfatih, Backs, Wolfgang   +8 more
core   +1 more source

Long-term efficacy and tolerability of lanthanum carbonate: Results from a 3-year study

, 2006
Background: Control of serum phosphate over the long term is essential in patients with end-stage renal disease. Six-month and 2-year extensions to a 6-month study evaluated the long-term safety, tolerability and efficacy of the new phosphate binder ...
Mohamed, Elfatih, Asmus, Gernot, Vanwalleghem, Johan, Backs, Wolfgang, Maes, Bart, Vosskühler, Andre, Hutchison, Alastair, Hutchison, Alastair J., Schmieder, Roland, Jamar, Rene   +9 more
core   +1 more source

Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: A 6-month, randomized, comparative trial versus calcium carbonate

, 2005
Background/Aims: Hyperphosphatemia is an important clinical consequence of renal failure, and its multiple adverse systemic effects are associated with significantly increased risks of morbidity and mortality in dialysis patients. Existing oral phosphate
Jamar, R., Vosskühler, A., Vanwalleghem, J., Schmieder, R., Backs, W., Mohamed, E., Asmus, G., Hutchison, Alastair, Maes, B., Hutchison, A. J.   +9 more
core   +1 more source